[HTML][HTML] Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility …

D Meirow, H Raanani, E Maman, S Paluch-Shimon… - Fertility and sterility, 2014 - Elsevier
Objective To evaluate the safety and efficacy of tamoxifen co-administration during
conventional controlled ovarian hyperstimulation (COH) protocols for a fertility-preservation …

Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen

K Oktay, E Buyuk, O Davis, I Yermakova… - Human …, 2003 - academic.oup.com
BACKGROUND: Breast cancer chemotherapy commonly causes premature ovarian failure
and infertility. Because increased estrogen levels are thought to be potentially risky in breast …

The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review

RJ Rodgers, GD Reid, J Koch, R Deans… - Human …, 2017 - academic.oup.com
STUDY QUESTION Can controlled ovarian hyperstimulation (COH) for fertility preservation
be effectively conducted in women with breast cancer without worsening their prognosis …

Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols

EME Balkenende, T Dahhan… - Human …, 2022 - academic.oup.com
STUDY QUESTION Does ovarian stimulation with the addition of tamoxifen or letrozole
affect the number of cumulus-oocyte complexes (COCs) retrieved compared to standard …

Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation

K Oktay, E Buyuk, N Libertella, M Akar… - Journal of Clinical …, 2005 - ascopubs.org
Purpose To develop safe ovarian stimulation methods to perform in vitro fertilization (IVF) in
breast cancer patients who wish to preserve their fertility via embryo cryopreservation before …

Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study

AA Azim, M Costantini-Ferrando… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Because of the accompanying increase in estrogen levels, safety of performing in
vitro fertilization (IVF) in women with breast cancer is unknown. Our goal was to determine …

[HTML][HTML] Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer

J Reddy, K Oktay - Fertility and sterility, 2012 - Elsevier
Breast cancer is the most common malignancy diagnosed in women in the United States.
Many breast cancer survivors are concerned that cancer treatment will compromise their …

Fertility preservation in young women undergoing breast cancer therapy

M Sonmezer, K Oktay - The oncologist, 2006 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Explain
how chemotherapy for breast cancer impacts ovarian function. Discuss the incidence of …

Fertility after breast cancer treatment

M Kasum, L Beketić-Orešković, PF Peddi… - European Journal of …, 2014 - Elsevier
In many countries of the developed world, there is an increasing trend toward delay in
childbearing from 30 to 40 years of age for various reasons. This is unfortunately concordant …

Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy

K Oktay, A Hourvitz, G Sahin, O Oktem… - The Journal of …, 2006 - academic.oup.com
Context: Women with breast cancer are not typically offered embryo or oocyte
cryopreservation to preserve their fertility before chemotherapy because of the potential risks …